Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma
Clinical trial NCT05204524 · UNKNOWN
Trial details
- NCT number
- NCT05204524
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-27
- Primary completion
- 2022-08-27
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.